Chris Markoch, Editor & Contributing Author at MarketBeat Articles by Chris Markoch - Page 7August 6, 2024 5:00 AM ETTyson Foods Crushes Earnings: Are New 52-Week Highs Ahead?Chris MarkochOn a day when the market is in a full sell-off mode, TSN stock is up more than 2%; strong year-over-year earnings growth shows its long-term strategy is workingNYSE:TSNRead Tyson Foods Crushes Earnings: Are New 52-Week Highs Ahead?August 2, 2024 7:14 AM ETChevron Stock Dips as Earnings Miss Highlights Merger UncertaintyChris MarkochChevron stock is falling after a mixed earnings report that showed earnings coming in lighter due to lower refining margins and natural gas pricesNYSE:CVXNYSE:MCDNYSE:HESRead Chevron Stock Dips as Earnings Miss Highlights Merger UncertaintyAugust 2, 2024 6:00 AM ETEA's New Game Launch Boosts Stock: Is It Time to Buy?Chris MarkochAfter an initial post-earnings surge, EA stock fell back leaving investors to wonder if the excitement over its College Football reboot is priced inNASDAQ:EARead EA's New Game Launch Boosts Stock: Is It Time to Buy?August 2, 2024 5:15 AM ETGenerac Raises Guidance: Why Is the Stock Still a Hold? Chris MarkochGenerac stock is having a sell-the-news event; GNRC stock is moving lower despite raising its full-year outlook for revenue and earningsNYSE:GNRCNYSE:WBXRead Generac Raises Guidance: Why Is the Stock Still a Hold? July 31, 2024 4:55 AM ET3 Must-Buy Stocks at Bargain Prices You Can't Afford to MissChris MarkochOne way for Investors to know the stocks they're buying offer real value is to look for stocks that are trading at, or near, their 52-week lowNYSE:VALENYSE:HALNASDAQ:LULURead 3 Must-Buy Stocks at Bargain Prices You Can't Afford to MissJuly 30, 2024 8:55 AM ETPharma Stock Cuts Earnings Outlook: Still a Buying OpportunityChris MarkochMerck stock is down more than 4% after lowering its 2024 earnings outlook, but if you look beyond the headline numbers, this could be a chance to buy the dipNYSE:MRKNYSE:ABBVRead Pharma Stock Cuts Earnings Outlook: Still a Buying OpportunityJuly 29, 2024 1:19 PM ETMcDonald’s Value is Down, But You Shouldn’t Count it OutChris MarkochAfter a bearish earnings report why is McDonald's stock running higher and how should investors take a bite out of MCD stock in the back half of the yearNYSE:MCDRead McDonald’s Value is Down, But You Shouldn’t Count it OutJuly 29, 2024 5:00 AM ETPicking Up the Pieces of the Tech Meltdown Chris MarkochAs investors rotate out of tech stocks, here are three names to consider if you’re looking to sift through the tech wreck for some attractive deals.NYSEARCA:SPYNASDAQ:QQQNASDAQ:SMCIRead Picking Up the Pieces of the Tech Meltdown July 22, 2024 7:15 AM ETExxon Mobil or Chevron – Which One May Be a Gusher for Investors?Chris MarkochExxon Mobil and Chevron are both excellent long-term investments, but with expectations of higher oil prices, one stocks looks to be a better short-term buyNYSE:XOMNYSE:CVXNYSE:HESRead Exxon Mobil or Chevron – Which One May Be a Gusher for Investors?July 20, 2024 5:07 AM ETWhy This AI Stock is Rising Despite Tech Sell-OffChris MarkochPLTR stock is up 67% in 2024, and it's up 11% in a month when investors are rotating out of tech stocks; there are reasons why the stock may not be done yetNYSE:PLTRNYSE:SNOWNASDAQ:NVDARead Why This AI Stock is Rising Despite Tech Sell-OffJuly 16, 2024 4:55 AM ETCan This AI Stock Keep Driving the Market Higher?Chris MarkochNVIDIA is one of the best-performing stocks in 2024 due to demand for AI applications, but there are reasons to ask how long it will move the market higherNASDAQ:NVDANASDAQ:MSFTNASDAQ:METARead Can This AI Stock Keep Driving the Market Higher?July 15, 2024 5:00 AM ETPositive News is Driving This Cancer Drug Maker’s Stock HigherChris MarkochIDEAYA Biosciences stock is up more than 16% on positive treatment data in a Phase 2 clinical trial, but after a 76% run-up, IDYA stock may need a breather NASDAQ:IDYANYSE:LLYNYSE:PFERead Positive News is Driving This Cancer Drug Maker’s Stock HigherJuly 10, 2024 9:03 AM ETAI Partnership Boosts This Top Tech Stock: Ready for More Gains?Chris MarkochPalantir stock is one of the best-performing stocks in 2024, and investors wonder if it has room to run higher; recent developments suggest it mayNYSE:PLTRNASDAQ:NVDANYSE:ORCLRead AI Partnership Boosts This Top Tech Stock: Ready for More Gains?July 5, 2024 6:41 AM ETTop 3 Retail Stocks Defying the Earnings Trend: AEO, PLAY, ROSTChris MarkochThe broader retail sector is under pressure, but these three retail stocks are beating earnings estimates and continue to issue bullish forecastsNASDAQ:LULUNYSE:AEONASDAQ:PLAYRead Top 3 Retail Stocks Defying the Earnings Trend: AEO, PLAY, ROSTJuly 3, 2024 10:45 AM ETAbbVie Stock: A Perfect Dip for Investors to BuyChris MarkochABBV stock is down over 3% to start the second half of the year; the stock may be overvalued in the short term but still offers value for long-term investorsNYSE:ABBVNYSE:JNJNYSE:PFERead AbbVie Stock: A Perfect Dip for Investors to BuyJuly 2, 2024 7:05 AM ETThe Top 4 Magnificent 7 Stocks to Buy in the Year's Second HalfChris MarkochAs investors rotated out of NVDA, they rotated into other Magnificent 7 stocks, which could continue their rally in the second half of 2024NASDAQ:AMZNNASDAQ:METANASDAQ:AAPLRead The Top 4 Magnificent 7 Stocks to Buy in the Year's Second HalfJune 27, 2024 5:04 AM ETAny Pullback in Tech May Signal a Rotation into These 3 SectorsChris MarkochInvestors who believe in diversification are waiting for the market to broaden out; instead of watching the Fed, look at the sectors institutions are buyingNASDAQ:NVDANASDAQ:MSFTNYSEARCA:XLERead Any Pullback in Tech May Signal a Rotation into These 3 SectorsJune 18, 2024 5:15 AM ET3 Strong Buy Stocks for a Sizzling Summer RallyChris MarkochInvestors can take a deep breath before the next earnings season, but they should still invest in equities, including these three gems hiding in plain sightNASDAQ:MSFTNASDAQ:NVDANASDAQ:AVGORead 3 Strong Buy Stocks for a Sizzling Summer RallyJune 17, 2024 9:51 AM ETBuffett Bails on BYD: What It Means for the Future of EV StocksChris MarkochWarren Buffett's hedge fund Berkshire-Hathaway continues to reduce its position in BYD stock, renewing concerns about Buffett's outlook on the EV industryOTCMKTS:BYDDYNYSE:BRK.BNASDAQ:TSLARead Buffett Bails on BYD: What It Means for the Future of EV StocksJune 14, 2024 5:05 AM ET3 High-Yield Dividend Stocks for Income Now and Growth LaterChris MarkochBuying high-yield dividend stocks at a low price today gives you current income with the opportunity for growth when interest rates come down later this yearNYSE:CVXNYSE:HESNYSE:BMYRead 3 High-Yield Dividend Stocks for Income Now and Growth LaterJune 12, 2024 5:35 AM ETBeyond GME: Top 3 WallStreetBets Stocks Better Than GameStopChris MarkochYou may want to keep an eye on the stocks the WallStreetBets community is watching; here are three that look like solid stocks to ownNYSE:AINASDAQ:CRWDNASDAQ:LULURead Beyond GME: Top 3 WallStreetBets Stocks Better Than GameStopJune 10, 2024 7:15 AM ETPalantir Was Left Out of the S&P 500; It Still Looks Like a BuyChris MarkochPalantir stock dropped about 2% after news that it will not be added to the S&P 500, but despite the short-term setback, PLTR is still a solid long-term buyNYSE:PLTRNASDAQ:CRWDNYSE:GDDYRead Palantir Was Left Out of the S&P 500; It Still Looks Like a BuyJune 7, 2024 5:52 AM ETChevron Stock Concerns: Perspectives Make the DifferenceChris MarkochAlthough Chevron has underperformed the broader market in the past 12 months, CVX stock is still a good buy for long-term investorsNYSE:CVXNYSE:XOMNYSE:HESRead Chevron Stock Concerns: Perspectives Make the DifferenceJune 4, 2024 7:55 AM ETBirkenstock Looks Like a Fit in Any Growth-Oriented PortfolioChris MarkochBirkenstock is trading close to its fair valuation after a 14% gain in the five days surrounding its earnings report, but investors will be able to buy any dipNYSE:BIRKNASDAQ:CROXNASDAQ:LULURead Birkenstock Looks Like a Fit in Any Growth-Oriented Portfolio Page 7 of 43 « Most Recent‹ More Recent45678910 Earlier › Earliest » Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
